These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35719954)
1. Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer. Wu S; Pan R; Lu J; Wu X; Xie J; Tang H; Li X Front Oncol; 2022; 12():896927. PubMed ID: 35719954 [TBL] [Abstract][Full Text] [Related]
2. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer. Li XF; Fu WF; Zhang J; Song CG BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia. Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393 [TBL] [Abstract][Full Text] [Related]
4. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
5. Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer. Yang Y; Du J; Huang YF; He W; Liu L; Li D; Chen R Oncol Lett; 2024 Feb; 27(2):43. PubMed ID: 38106522 [TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes. Yan C; Liu Q; Jia R Front Oncol; 2022; 12():829045. PubMed ID: 35186763 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of the ferroptosis-related Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P Front Oncol; 2023; 13():1032364. PubMed ID: 37064114 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and triple-negative breast cancer: Potential therapeutic targets. Xu N; Li B; Liu Y; Yang C; Tang S; Cho WC; Huang Z Front Oncol; 2022; 12():1017041. PubMed ID: 36568247 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer. Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558 [TBL] [Abstract][Full Text] [Related]
10. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer. Zhang J; Zhang M; Tian Q; Yang J Clin Exp Med; 2023 Nov; 23(7):3867-3881. PubMed ID: 37219794 [TBL] [Abstract][Full Text] [Related]
11. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics. Pan J; Zhang X; Fang X; Xin Z Front Genet; 2021; 12():739470. PubMed ID: 34497636 [TBL] [Abstract][Full Text] [Related]
12. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer. Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer. Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma. Wang Y; Chen W; Zhu M; Xian L Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526 [No Abstract] [Full Text] [Related]
16. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma. Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551 [TBL] [Abstract][Full Text] [Related]
17. Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer. Chen X; Ren C; Zhou Z; Chen J; Fan X; Li X; Chen J; Zhu J J Gene Med; 2024 Jan; 26(1):e3584. PubMed ID: 37605934 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma. Chen Z; Wu T; Yan Z; Zhang M Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910 [TBL] [Abstract][Full Text] [Related]
19. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma. Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Tao Y; Wang X PeerJ; 2021; 9():e11687. PubMed ID: 34277151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]